YTHDF1 Control of Dendritic Cell Cross-Priming as a Possible Target of Cancer Immunotherapy
Biochemistry
.
2019 Apr 16;58(15):1945-1946.
doi: 10.1021/acs.biochem.9b00200.
Epub 2019 Apr 3.
Authors
Daniel J Kim
1
,
Akiko Iwasaki
1
2
3
Affiliations
1
Department of Immunobiology , Yale School of Medicine , New Haven , Connecticut 06519 , United States.
2
Department of Molecular, Cellular, and Developmental Biology , Yale University , New Haven , Connecticut 06520 , United States.
3
Howard Hughes Medical Institute , Chevy Chase , Maryland 20815 , United States.
PMID:
30943019
DOI:
10.1021/acs.biochem.9b00200
No abstract available
Publication types
Comment
MeSH terms
Cross-Priming*
Dendritic Cells
Humans
Immunotherapy
Methylation
Neoplasms*
RNA, Messenger
RNA-Binding Proteins
Substances
RNA, Messenger
RNA-Binding Proteins
YTHDF1 protein, human